Home > Hematology - Oncology Therapy
Canada
0 items -
$0.00
eStore Cart
Shopping Cart
items
Now Loading
Total Saving
$0
Subtotal
$0
close X
our categories
view larger cover

Hematology - Oncology Therapy

© 2014
by Michael Boyiadzis James Frame David R. Kohler Tito Fojo

2nd Edition Active, In-Print 1888 Pages Hardcover
9780071637893 0071637893

$182.95

buy now

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens

More than 500 treatment regimens

Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform
manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information
that is critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into three sections:

Oncology:

Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved
chemotherapeutic regimens, drugs, and biological agents

Supportive Care, Drug Preparation, Complications, and Screening:

Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more

Selected Hematologic Diseases:

Delivers an authoritative guide to therapy for the principal diseases in consultative hematology

This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.

Authors

Preface

SECTION I: ONCOLOGY

1. Adrenocortical Cancer, Peter F. Lebowitz and Tito Fojo

2. Anal Cancer, David Ryan and Robert Mayer

3. Biliary Tract Cancer: Gallbladder Cancer and Cholangiocarcinoma, Verena Sagaster and Werner Scheithauer

4. Bladder Cancer, Edwin M. Posadas and William L. Dabut

5. Brain Cancer, Lyndon Kim and Howard Fine

6. Breast Cancer, Peter F. Lebowitz and Jo Anne Zujewski

7. Carcinoid Tumors, Eva Tiensuu Janson and Kjell Oberg

8. Carcinoma of Unknown Primary, David Spigel and F. Anthony Greco

9. Cervical Cancer, Deirdre O'Mahony and Peter Rose

10. Colorectal Cancer, Gregory Leonard and Jean Grem

11. Endometrial Cancer, Deirdre O'Mahoney and Franco Muggia

12. Esophageal Cancer, Gauri Varadhachary and Jaffer Ajani

13. Gastric Cancer, Manish A. Shah, Dana Rathkopf, and Gary K. Schwartz

14. Gestational Trophoblastic Neoplasia, Michael M. Boyiadzis and John Lurain

15. Head and Neck Cancers, Erin Donovan and Barbara Conley

16. Hepatocellular Carcinoma, Joan Maurel and Jordi Bruix

17. HIV-Related Malignancies, Pallavi Kumar and Richard F. Little

18. Leukemia, Acute Lymphoblastic (Adult), Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp

19. Leukemia, Acute Myelogenous, Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp

20. Leukemia, Chronic Lymphocytic, Salah Abbasi and Bruce D. Cheson

21. Leukemia, Chronic Myelogenous, Michael W.N. Deininger and Brian J. Druker

22. Leukemia, Hairy Cell, Martin S. Tallman

23. Lung Cancer, Enriqueta Felip and Rafael Rosell

24. Lymphoma, Hodgkin, Christina M. Annunziata and Dan L. Longo

25. Lymphoma, Non-Hodgkin, Kieron Dunleavy, David R. Kohler, and Wyndham H. Wilson

26. Melanoma, Michael M. Boyiadzis and Barry Gause

27. Mesothelioma, Verna Vanderpuye and Nicholas J. Vogelzang

28. Multiple Myeloma, Robert Dean and Cynthia E. Dunbar

29. Ovarian Cancer, Eddie Reed

30. Pancreatic Cancer, Michael M. Boyiadzis and Daniel D. Von Hoff

31. Pheochromocytoma, Michael M. Boyiadzis, Karel Pacak, and Tito Fojo

32. Prostate Cancer, Peter F. Lebowitz and William L. Dabut

33. Renal Cell Carcinoma, Michael M. Boyiadzis and Susan Bates

34. Sarcomas, Janice Walshe, Tito Fojo, and Lee Helman

35. Testicular Cancer, Michael M. Boyiadzis and Scott Saxman

36. Thymic Carcinoma, Hanneke Wilmink and Guisseppe Giaconne

37. Thyroid Cancer, Kenneth B. Ain

38. Vaginal Cancer, Thomas Chen and Franco Muggia

SECTION II: SUPPORTIVE CARE, DRUG PREPARATION, COMPLICATIONS, AND SCREENING

39. Chemotherapy-Induced Nausea and Vomiting: Prophylaxis and Treatment, Thomas E. Hughes

40. Drug Preparation and Administration, David R. Kohler

41. Chemotherapy Dose Modifications, Michael Menefee, Pamela W. McDevitt, and Tito Fojo

42. Antineoplastic Drugs: Preventing and Managing Extravasation, David R. Kohler

43. Indications for Growth Factors in the Hemotology-Oncology Setting, Pamela W. McDevitt and James N. Frame

44. Indications for Bisphosphonates in the Hematology-Oncology Setting, Reem A. Shalabi, David R. Kohler, and James N. Frame

45. Transfusion Therapy, Ashok Nambiar and Susan Leitman

46. Oncologic Emergencies, Michael M. Boyiadzis and Tito Fojo

47. Fever and Neutropenia, Juan Gea-Banacloche and Thomas J. Walsh

48. Catheter-Related Bloodstream Infections: Managing and Prevention, Naomi P. O'Grady

49. Venous Catheter-Related Thrombosis, McDonald Horne

50. Complications and Follow-up After Hematopoietic Stem Cell Transplantation (HSCT), Michael M. Boyiadzis, Juan Gea-Banacloche, and Michael R. Bishop

51. Radiation Complications, Diana Stripp and Eli Glatstein

52. Cancer Pain: Assessment and Management, Ann Berger

53. Hospice Care and End-of-Life Issues, Charles F. Von Gunten and David Weismann

54. Cancer Screening, Jennifer Eng-Wong, Kathleen Calzone, and Sheila A. Prindiville

55. Genetics of Common Inherited Cancer Syndromes, Kathleen Calzone, Jennifer Eng-Wong, and Sheila A. Prindiville

SECTION III: SELECTED HEMATOLOGIC DISEASES

56. von Willebrand Disease, Michael M. Boyiadzis and Margaret E. Rick

57. Hemophilia, Steven J. Jubelirer

58. The Hypercoagulable State, Jeffrey I. Zwicker and Kenneth A. Bauer

59. Heparin-Induced Thrombocytopenia (HIT) and HIT with Thromboembolic Syndrome (HITTS), McDonald K. Horne, III

60. Autoimmune Hemolytic Anemia, James N. Frame

61. Sickle Cell Disease: Acute Complications, James N. Frame, Steven J. Jubelirer, and Griffin P. Rodgers

62. Aplastic Anemia, Michael M. Boyiadzis and Neal S. Young

63. Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS), Kiarash Kojouri and James N. George

64. Idiopathic Thrombocytopenic Purpura, Kiarash Kojouri and James N. George

65. Polycythemia Vera, Celia L. Grosskreutz and Steven Fruchtman

66. Essential Thrombocythemia, Celia L. Grosskreutz and Steven Fruchtman

67. Myelodysplastic Syndromes, Michael M. Boyiadzis and Neal S. Young

All requests will be pre-qualified by a McGraw-Hill representative before forwarding shipment to your university or college campus address.

Click here to request an Academic review copy.